Drug Shortage Report for BIPHENTIN
Report ID | 157373 |
Drug Identification Number | 02277212 |
Brand name | BIPHENTIN |
Common or Proper name | methylphenidate hydrochloride Controlled Release Capsules |
Company Name | ELVIUM LIFE SCIENCES |
Market Status | MARKETED |
Active Ingredient(s) | METHYLPHENIDATE HYDROCHLORIDE |
Strength(s) | 80MG |
Dosage form(s) | CAPSULE (EXTENDED RELEASE) |
Route of administration | ORAL ORAL |
Packaging size | 50 |
ATC code | N06BA |
ATC description | PSYCHOSTIMULANTS AND NOOTROPICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | 2022-03-24 |
Actual start date | 2022-03-24 |
Estimated end date | 2023-06-07 |
Actual end date | 2023-06-08 |
Shortage status | Resolved |
Updated date | 2023-06-09 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3381 STEELES AVENUE EAST TORONTO, ONTARIO CANADA M2H 3S7 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v111 | 2023-06-09 | English | Compare |
v110 | 2023-06-08 | French | Compare |
v109 | 2023-06-08 | English | Compare |
v108 | 2023-06-06 | French | Compare |
v107 | 2023-06-06 | English | Compare |
v106 | 2023-05-26 | French | Compare |
v105 | 2023-05-26 | English | Compare |
v104 | 2023-05-18 | French | Compare |
v103 | 2023-05-18 | English | Compare |
v102 | 2023-05-12 | French | Compare |
v101 | 2023-05-12 | English | Compare |
v100 | 2023-05-05 | French | Compare |
v99 | 2023-05-05 | English | Compare |
v98 | 2023-05-04 | French | Compare |
v97 | 2023-05-04 | English | Compare |
v96 | 2023-05-01 | French | Compare |
v95 | 2023-05-01 | English | Compare |
v94 | 2023-04-28 | French | Compare |
v93 | 2023-04-28 | English | Compare |
v92 | 2023-04-21 | French | Compare |